5 ms·
3. When pharmaceutical companies denied the risk of novel gene therapies for inoculation against a family of cold viruses.
by sk2020 5y ago
3. When pharmaceutical companies denied the risk of novel gene therapies for inoculation against a family of cold viruses.
- rendall 5y ago4. Ditto for the risks of OxyContin: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2622774/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2622774/